Wilson Sonsini is pleased to have represented Forte Biosciences in its recently completed acquisition by argenx.

Our role as legal advisor to Forte Biosciences highlights Wilson Sonsini's strength as a premier legal partner for life sciences companies, backed by a proven track record in public company M&A. This long-standing relationship with Forte Biosciences, spanning multiple financings, public offerings, shareholder activism, and intellectual property representation, reflects the firm's ongoing commitment to supporting innovative companies in the life sciences industry throughout their entire life cycle.

For more information on the Wilson Sonsini team that advised Forte Biosciences, please see our client highlight announcing the acquisition. For more information, please see argenx's news release.